Menarini reports Phase 3 data for selinexor plus ruxolitinib in myelofibrosis
Roche secures IVDR approval to expand VENTANA MMR RxDx Panel indications
Guardant Health expands FDA-approved companion diagnostic use for HERNEXEOS
FDA grants priority review for Genentech's Tecentriq in stage III dMMR/MSI-H colon cancer
Harbour BioMed IND for HBM7004 accepted by China's NMPA
FDA grants rare paediatric disease designation to RedHill's opaganib
GSK to acquire Nuvalent for USD10.6bn to expand lung cancer portfolio
Curasight reports encouraging preliminary Phase 1 data for uTREAT in glioblastoma
OriCell's GPC3 CAR-T Phase II hepatocellular carcinoma trial receives Chinese regulatory clearance
Owkin to build AI agents as part of K Pro collaboration with Sanofi
Lupin and Natco secure US FDA approval for generic Eribulin Mesylate Injection
Evogene completes Phase 1 study of BMC128 in combination with Nivolumab